H.Lee Moffitt Cancer center

Tampa, Florida 33624

5 studies enrolling now · 165 studies all time

What they study most

Acquired Aplastic Anemia, Acral/Lentiginous Melanoma, Acute GVHD, Acute Graft Versus Host Disease, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia, Acute Myelogenous Leukemia (AML or ANLL), Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia in Remission

Studies at this site

• A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer — Recruiting now
• A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) — Recruiting now
• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) — Recruiting now
• A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer — Recruiting now
• A Study of TAK-505 in Adults With Solid Tumors — Recruiting now
• Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL) — Recruiting now
• A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab — Recruiting now
• Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer — Running, not enrolling
• Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations — Running, not enrolling
• Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507) — Completed
• HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903 — Completed
• Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events — Stopped early
• Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors — Running, not enrolling
• Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma — Completed
• Improving Outcomes Assessment in Chronic GVHD — Running, not enrolling
• A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) — Running, not enrolling
• Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) — Completed
• Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 1 and Cohort 2) — Completed
• Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor — Completed
• Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma — Available (expanded access)
• A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer — Running, not enrolling
• Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 — Running, not enrolling
• Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) — Completed
• A Study of Axicabtagene Ciloleucel in Participants With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma — Completed
• MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC — Completed
• Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer — Running, not enrolling
• Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT) — Running, not enrolling
• NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors — Stopped early
• Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies — Completed
• (PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis — Running, not enrolling
• A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer — Completed
• Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC — Running, not enrolling
• Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03) — Running, not enrolling
• Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma — Completed
• MEND 2: Making Treatment Decisions Using Genomic Testing — Completed
• APR-548 in Combination With Azacitidine for the Treatment of TP53 Myelodysplastic Syndromes (MDS) — Stopped early
• Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination — Completed
• TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer — Completed
• A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML) — Completed
• A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3) — Completed
• A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma — Completed
• A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002) — Stopped early
• Decitabine Versus Supportive Care in Adults With Advanced-stage MDS — Completed
• ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma — Status unconfirmed
• A Study of a Monoclonal Antibody, KW-2871, in Patients With Advanced Melanoma — Stopped early
• Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid Tumors — Completed
• Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL — Completed
• A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma — Completed
• TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801) — Completed
• Study of Safety and Efficacy of KTE-C19 in Combination With Atezolizumab in Adults With Refractory Diffuse Large B-Cell Lymphoma (DLBCL) — Completed